Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 177

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Microbial biofilm formation: a need to act

Römling, U., Kjelleberg, S., Normark, S., Nyman, L., Uhlin, B. E., Åkerlund, B.·2014·Journal of Internal Medicine

Abstract

The interdisciplinary Biofilm Nobel conference aimed not only to cover recent progress in this research area, but also to bridge basic science and clinical disciplines. As such, the conference gathered leading investigators who collectively covered the broad spectrum of biofilm research from the molecular analysis of basic phenomena to the clinical impact and the prevention of biofilm formation (http://biofilmnobelconference.org/). Broad scoping topics were thematically organized during the five keynote lectures, nine sessions, and 67 posters. From a medical perspective, these included the clinical problem of persistent infections by biofilm-forming microorganisms in device-related as well as soft tissue infection, the molecular basis of foreign body infections; biofilms and the immune system; and biofilms and cancer. Important fundamental discoveries made in basic biofilm research with respect to structure and regulation of biofilm formation were presented, along with biofilm diagnostics, bioinformatics of biofilm formation, the resistance phenotype, and prevention of biofilm formation. Various strategies to treat biofilm infections were also discussed. Although biofilm formation was observed as early as 1708 when Antonie van Leeuwenhoek investigated tissue colonized by microbes with his new, and at that time, highly powerful microscope, research on biofilm formation only began to make significant advances in the last 15–20 years with exponential growth (Table 1). It is recognized that the developmental process of biofilm formation (the association of bacteria into multicellular consortia, consisting of still autonomous cells connected by an extracellular matrix) is not only the natural mode of life of many microorganisms 1, 2, but also an important clinical pathogenic mechanism 3, 4 strengthened by the aging population, immunocompromised and olytraumatic patients, and modern medical instrumental intervention (Fig. 1). In the USA alone, it is estimated that 1.7 million hospital-acquired infections annually involve microorganisms in the biofilm state, incurring an additional $11 billion in healthcare costs (US CDC, 2007). The total annual cost for biofilm infections in the USA is unofficially estimated to be $94 billion with more than half a million deaths 5. The dimension of community acquired biofilm infections is also huge, with, e.g., US$105 billion spent on dental care alone, making dental caries and periodontitis the most prevalent biofilm-associated diseases 3. The spectrum of biofilm diseases is wide. While catheter-associated urinary tract infection (CAUTI) is the most common device-associated biofilm infection, central line-associated blood stream infections (CLABSI) and ventilator-associated pneumonia (VAP) are also of significant concern (Fig. 1). Although historically the most prominent biofilm-associated disease might be Pseudomonas aeruginosa-mediated lung infection in cystic fibrosis (CF) patients 6, soft tissue infections, e.g., diabetic foot ulcers and mucosal infections, including chronic and recurrent urinary tract infections, are main biofilm-associated diseases of today (Fig. 1). Basic science research has demonstrated that antibiotic resistance is transferred readily in biofilms. In line with this, Escherichia coli isolated from medical devices showed the highest incidence of resistance against cefuroxime and ciprofloxacin compared to isolates obtained from other body sites 7. CAUTI and prosthetic joint infections are two of the most relevant biofilm-associated foreign body infections, with great economical significance in health care 5. CAUTI, which accounts for 15% of all infections, is the second most common healthcare-associated infection in the USA, and virtually, all healthcare UTIs are associated with indwelling devices (http://www.cdc.gov/nhsn/pdfs/pscmanual/7psccauticurrent.pdf). The design of the Foley urinary tract catheter in use today has basically not changed since its invention in the 1930s. The probability that the catheter becomes infected is 1–5% per day, and after 4 weeks, nearly all patients will have high bacterial numbers in the urine 8. The high likelihood of microbial colonization arises as the Foley catheter undermines the local defense system in the urinary tract. Although there is an urgent need for catheter amelioration, until recently, there has been no development of catheters with novel design and material 8. Biofilm infections are costly. After hip or knee joint replacement, a prosthetic joint infection (PJI) with revision of the prosthesis is estimated to be $50–100 000 per patient. The PJI incidence within the first two postoperative years is 0.5–2%. As the number of arthroplasties in the USA is extrapolated to four million in 2030 from the one million in 2009 9, the incidence of PJIs will increase accordingly. Diagnosis of PJIs frequently requires approaches beyond standard microbiological tests 10. Biofilm infections are typically difficult to diagn

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/joim.12242

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 177

Metadata

Authors
Römling, U., Kjelleberg, S., Normark, S., Nyman, L., Uhlin, B. E., & Åkerlund, B.
Venue
Journal of Internal Medicine
Publisher
Wiley
Published
2014-05-06
Volume
276
Issue
2
Pages
98-110
ISSN
  • 0954-6820 (ISSN-L)
  • 1365-2796
OpenAlex
W2089854781
Cited by
177
References
12
FWCI
5.35
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microbial biofilm formation: a need to act. https://app.cochat.ai/papers/10.1111/joim.12242
The paper
Römling, U., Kjelleberg, S., Normark, S., Nyman, L., Uhlin, B. E., & Åkerlund, B. (2014). Microbial biofilm formation: a need to act. Journal of Internal Medicine. https://doi.org/10.1111/joim.12242

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.